Physician profile
Stacey E Hurst
NPI 1265905749
$1,216.47
in general payments reported to CMS, 2019-2025
13 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $752 · 2023: $92.28 · 2024: $57.61 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $494.36 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.52 | 2022-2025 | Ofev |
| Sk Life Science, INC. | $97.68 | 2022 | |
| Jazz Pharmaceuticals INC. | $92.87 | 2021-2023 | |
| Itamar Medical INC | $76.20 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $43.87 | 2022 | |
| Pfizer INC. | $41.29 | 2024 | |
| Lilly USA, LLC | $35.42 | 2023-2024 | Emgality, Jardiance, Zepbound |
| Axsome Therapeutics, INC. | $30.38 | 2022-2023 | Auvelity |
| Resmed Corp | $28.02 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $21.70 | 2025 | Uzedy |
| Astrazeneca Pharmaceuticals Lp | $18.59 | 2025 | |
| Radius Health, INC. | $15.57 | 2025 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Hurst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.